NORDEA INVESTMENT MANAGEMENT AB - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORDEA INVESTMENT MANAGEMENT AB ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,415,782
-35.2%
764,488
-1.4%
0.00%
-40.0%
Q2 2023$3,729,169
+14.8%
775,295
+20.1%
0.01%0.0%
Q1 2023$3,247,509
-16.8%
645,628
-1.1%
0.01%
-16.7%
Q4 2022$3,903,834
-43.9%
652,815
-1.7%
0.01%
-45.5%
Q3 2022$6,955,000
-11.7%
664,302
-5.0%
0.01%
-8.3%
Q2 2022$7,873,000
+8.2%
699,208
-8.0%
0.01%
+33.3%
Q1 2022$7,278,000
+12.6%
759,676
+82.0%
0.01%
+12.5%
Q4 2021$6,462,000
-18.4%
417,439
+36.7%
0.01%
-20.0%
Q3 2021$7,922,000
-2.4%
305,411
-1.9%
0.01%
-9.1%
Q2 2021$8,119,000
+37.0%
311,306
+84.2%
0.01%
+22.2%
Q1 2021$5,928,000
+33.6%
168,983
-3.9%
0.01%
+28.6%
Q4 2020$4,437,000
-34.0%
175,806
-1.9%
0.01%
-46.2%
Q3 2020$6,718,000
-54.9%
179,244
-49.6%
0.01%
-13.3%
Q2 2020$14,894,000
+330.3%
355,546
+100.0%
0.02%
+87.5%
Q1 2020$3,461,000
-22.6%
177,769
+3.9%
0.01%
-11.1%
Q4 2019$4,470,000171,1310.01%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders